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Approximately one-third of the human colonic microbiome is formed
by bacteria from the genus Bacteroides. These bacteria produce a large amount of
uniformly sized outer membrane vesicles (OMVs), which are equipped with hydrolytic enzymes that play a role in the degradation of diet- and host-derived glycans.
In this work, we characterize the lipid composition of membranes and OMVs from
Bacteroides thetaiotaomicron VPI-5482. Liquid chromatography-mass spectrometry
(LC-MS) analysis indicated that OMVs carry sphingolipids, glycerophospholipids, and
serine-dipeptide lipids. Sphingolipid species represent more than 50% of the total
lipid content of OMVs. The most abundant sphingolipids in OMVs are ethanolamine
phosphoceramide (EPC) and inositol phosphoceramide (IPC). Bioinformatics analysis
allowed the identiﬁcation of the BT1522–1526 operon putatively involved in IPC synthesis. Mutagenesis studies revealed that BT1522–1526 is essential for the synthesis
of phosphatidylinositol (PI) and IPC, conﬁrming the role of this operon in the biosynthesis of IPC. BT1522–1526 mutant strains lacking IPC produced OMVs that were
indistinguishable from the wild-type strain, indicating that IPC sphingolipid species
are not involved in OMV biogenesis. Given the known role of sphingolipids in immunomodulation, we suggest that OMVs may act as long-distance vehicles for the
delivery of sphingolipids in the human gut.
IMPORTANCE Sphingolipids are essential membrane lipid components found in

eukaryotes that are also involved in cell signaling processes. Although rare in bacteria, sphingolipids are produced by members of the phylum Bacteroidetes, human
gut commensals. Here, we determined that OMVs carry sphingolipids and other lipids of known signaling function. Our results demonstrate that the BT1522–1526 operon is required for IPC biosynthesis in B. thetaiotaomicron.
KEYWORDS Bacteroides, OMV, ceramide, sphingolipids

F

rom birth, the mammalian gastrointestinal tract is colonized by tens of trillions of
microorganisms (1, 2). The sum of all microbes within an organism, or the microbiome, has been found to be key for the development of the host immune system (3–
7). Increasing evidence suggests that alterations in the mammalian colonic microbiome
can inﬂuence host health and disease outcomes (8–11). Moreover, gut disease in
humans has been associated with altered microbial metabolic pathways (12, 13).
Approximately one-third of the human colonic microbiome is formed by bacteria from
the genus Bacteroides, which specializes in the degradation of complex dietary polysaccharides (1, 2, 14). Bacteroides thetaiotaomicron, a common human gut commensal,
has been recognized as both beneﬁcial and detrimental to the host, according to
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different murine models of inﬂammatory disease (15–17). Components of the Bacteroides
cell envelope, such as the capsule, proteins with hydrolytic activity, and outer membrane
vesicles (OMVs), have been implicated in shaping host-symbiont interactions (17–19).
Our group has shown that a subset of proteins from Bacteroides spp. predicted to
localize to the outer membrane (OM) are preferentially enriched in OMVs (20–22). OMVs
are spherical outer membrane-derived structures that contain outer membrane and periplasmic proteins, lipids, and other molecules such as lipopolysaccharides and capsules
(23–25). The proteins enriched in OMVs are mainly lipoproteins with either glycosidase
or protease activity that play a role in the digestion of complex nutrients. The intrinsic
properties of these proteins, such as their isoelectric points and the presence of lipoprotein export signals (LES), account for their enrichment into OMVs (21, 22). However, while
Bacteroides OMV cargo proteins have been well described, the lipid composition of
OMVs and the effect of lipids on OMV biogenesis and cargo selection remain elusive.
Although rare in bacteria, sphingolipids are produced by members of the phyla
Bacteroidetes and Proteobacteria (26–29). Sphingolipids are ubiquitous and structurally diverse polar lipids, essential for eukaryotic cell membrane homeostasis (30).
Different sphingolipids have been linked to a plethora of cell signaling processes,
including cell death, proliferation, growth, and migration (31). These bioactive molecules have also been shown to play important roles in the development of metabolic
disorders, including the ability to interfere with cholesterol absorption and insulin resistance (32–34). Furthermore, microbially derived membrane sphingolipids have been
linked to reduced inﬂammatory disease in humans and germfree mouse models (35,
36). Species from the phylum Bacteroidetes, including the human commensals
Bacteroides and Porphyromonas, synthesize sphingolipids as the main constituents of
their membranes (26, 35, 37–41). Despite the knowledge that members of the human
microbiota produce eukaryotic-like lipids that are associated with health and disease
states, there has been a paucity of mechanistic insights into the biosynthesis of bacterial sphingolipids and their role in host-commensal interactions (26, 36, 38, 42). Mutant
strains of Bacteroides fragilis and B. thetaiotaomicron unable to produce sphingolipids
show lower in vitro stress resistance, poor colonization phenotypes, and a failure to
elicit anti-inﬂammatory host immune responses (35, 37, 38, 40, 43).
Although these Bacteroides-derived lipids play a key role in host inﬂammatory processes, their impact on OMV biogenesis and cargo selection remains unknown. We
hypothesize that speciﬁc lipids selectively partition to OMVs, where they participate in
the formation and recruitment of speciﬁc protein cargo, which could impact
Bacteroides-host interactions. To test this hypothesis, we ﬁrst performed a lipidomics
analysis of the total membranes (TM) and OMVs from B. thetaiotaomicron VPI-5482.
Our data show that OMVs contain diverse sphingolipids, glycerophospholipids, and
glycine-serine dipeptide lipids (GS). The most abundant sphingolipids are ethanolamine phosphoceramide (EPC) and inositol phosphoceramide (IPC). Genetic approaches
and mass spectrometry analysis allow the identiﬁcation of the IPC biosynthetic pathway. Our results indicate that IPC sphingolipids do not exert signiﬁcant effects on OMV
biogenesis and, indeed, OMVs might serve as IPC delivery vehicles, contributing to the
regulation of host-symbiont interactions.
RESULTS
OMVs contain sphingolipids, glycerophospholipids, and serine dipeptide lipids.
In Bacteroidetes, the protein compositions of OMVs and the membranes from which
they derive are strikingly different, with several proteins excluded from or exclusively
present in OMVs (20–22, 44). We hypothesized that interaction of these proteins with
lipids could be involved in the exclusion or recruitment of proteins into OMVs. In this
model, it is conceivable that particular lipid species also partition between total membranes (TM) and OMVs. We employed a combination of liquid chromatography and
untargeted mass spectrometry (LC-MS) to analyze the lipid contents from TM and
OMVs produced by B. thetaiotaomicron VPI-5482. Mass-to-charge ratios (m/z) in
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negative ion mode were utilized to assign each MS peak to the most probable lipid
species. When required, we employed online resources from the publicly available
LIPID MAPS Lipidomics Gateway (45–47) for prediction of the lipid species based on
the m/z values. We determined that B. thetaiotaomicron OMVs contain sphingolipids,
glycerophospholipids, and serine dipeptide lipids (Table S1). Our analyses showed
minor differences in the lipid composition of TM and OMV fractions (Fig. 1). However,
it revealed interesting features of OMV lipids.
The most ubiquitous lipid class found in bacteria, glycerophospholipids, is widely
represented in TM and OMV fractions from B. thetaiotaomicron by the lipid species
phosphatidylethanolamine (PE) (m/z values, 620.44, 634.5, 648.5, 662.5, 676.5) and
phosphatidylinositol (PI) (m/z values, 767.5, 781.5, 795.5) (Fig. 1A). A remarkable feature
of lipids from Bacteroidetes is the presence of acylated amino acids (48). Acylated
amino acids such as ornithine lipid and commendamide have been found in other bacterial taxonomic groups (49, 50). Acylated glycine-serine dipeptide lipids (GS) have
been found and studied in the Bacteroidetes taxons Flavobacterium spp., Porphyromonas
gingivalis, and B. thetaiotaomicron (51–55). Our data showed that GS (m/z values, 639.5,
653.5) were present in both B. thetaiotaomicron TM and OMV fractions (Fig. 1B).
The most abundant lipid species found in OMVs were sphingolipids, mainly ceramide (m/z values, 600.4, 614.5, 628.5) and ceramide-derived compounds, including
ethanolamine phosphoceramide (EPC) (m/z values, 663.5, 677.5, 691.5, 705.6) and inositol phosphoceramide (IPC) (m/z values, 796.5, 810.5, 824.6) (Fig. 1A; Table S1). EPC has
been found in B. fragilis, B. thetaiotaomicron, and Bacteroides ovatus (56). IPC, a sphingolipid typically found in eukaryotes, has been discovered in B. thetaiotaomicron and
B. ovatus (35, 38, 43). However, neither of the biosynthetic pathways of these sphingolipids has been elucidated.
Genetic basis of IPC synthesis. We postulated that sphingolipids may be involved
in OMV biogenesis and sought to study OMVs in a mutant strain unable to produce
this class of lipids. The ﬁrst step in sphingolipid biosynthesis is the synthesis of 3-dehydroxysphinganine using palmitoyl-coenzyme A (CoA) and serine as the substrates via
serine palmitoyl transferase (SPT). SPT orthologs are conserved in Bacteroidetes and
carry the same function as in eukaryotes (35, 37, 39, 40, 43). Recent work has identiﬁed
the spt ortholog in B. thetaiotaomicron, BT0870, and shown its essential function in
sphingolipid biosynthesis (35). We generated a deletion strain for spt in B. thetaiotaomicron using a thymidine kinase (tdk) mutant strain as our wild-type (WT) genetic background, allowing for negative selection of transconjugants (57). Deletion of spt, as
expected, resulted in a B. thetaiotaomicron strain unable to synthesize sphingolipids, as
indicated by LC-MS (Fig. S1). The complete absence of sphingolipids caused a drastic
reduction in bacterial growth and lysis, which made analysis of the contribution of
OMV sphingolipids in B. thetaiotaomicron unfeasible (Fig. S1). Thus, we sought to investigate the roles of speciﬁc sphingolipids, such as EPC and IPC, in OMV formation. We
performed BLAST analyses against the B. thetaiotaomicron VPI-5482 proteome using
amino acid sequences from eukaryotic EPC and IPC synthases (CPES from Drosophila
melanogaster and AUR1 from Saccharomyces cerevisiae). While no matches were found
for EPC synthase, we found a putative ortholog in B. thetaiotaomicron, BT1522, predicted to encode an IPC synthase. Analysis of the genes surrounding BT1522 suggested
that BT1522 is part of an operon composed of genes BT1522 to BT1526 (35). We
employed PSI-BLAST, HHpred, and Phyre2 to interrogate the function of the predicted
proteins encoded by the BT1522–1526 operon (Fig. 2A) and generate a predicted IPC
biosynthetic pathway (Fig. 2B) (58–60). BT1526 is annotated as a myo-inositol-phosphate synthase, an enzyme that generates myo-inositol-3-phosphate from glucose-6-P
(Fig. 2B) (61, 62). Myo-inositol 3-phosphate is the building block for most phosphoinositol-derived compounds (61, 62). BT1525 is predicted to encode a phosphatidylglycerol-1-phosphate (PGP) phosphatase, an enzyme that generates phosphatidylglycerol
using PGP as the substrate (Fig. 2A) (63). BT1524 is predicted to encode a GtrA-like protein, an inner membrane protein that seems to be required for synthesis of lipid-linked
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FIG 1 Lipid species diversity and distribution in OMVs and TM from B. thetaiotaomicron. Label-free quantiﬁcation using LC-MS of lipid species from OMVs
and TM of wild-type B. thetaiotaomicron. (A) ESI MS spectra showing absolute counts of the [M–H]2 ions of various lipids (mainly sphingonoids) from
extracts of OMV (upper panels) and TM (lower panels) and the signal averaged spectra of LC fractions 15.5 to 17.6 (i) and 19.4 to 21.7 (ii) min, respectively.
IPC, inositol phosphoceramide; EPC, ethanolamine phosphoceramide; PE, phosphatidylethanolamine; PI, phosphatidylinositol; DHC, dihydroceramide; GS,
glycine-serine dipeptide lipids. The fatty acyl chain, e.g., “15:0/ b h17:0,” indicates “C15 fatty acyl (FA) chain with no double bond” and “C17 chain with
b -hydroxy side chain with no double bond,” respectively. “d17:0” represents “dihydroxy-17:0 LCB” (LCB, long-chain base). (B) Relative abundance of the
most represented lipid species as a percentage of the total lipid composition for each fraction. The assigned structures (as labeled in each section in panel
A) are based on tandem MS analysis of the individual ions, and the designation of the structures is according to LIPID MAPS with modiﬁcations. The graph
shows the median values and standard deviation of four biological replicates.
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glycans in bacteria (64–66). BT1523 is predicted to encode a phosphatidylinositol (PI)
synthase, which utilizes inositol and cytidine diphosphate (CDP)-diacylglycerol to synthesize phosphatidylinositol (Fig. 2B) (67). Finally, an IPC synthase (BT1522) generates
IPC in eukaryotes using ceramide and phosphatidylinositol as the substrates (Fig. 2B)
(68, 69). To generate clean deletion mutant strains for genes BT1522 to BT1526, we
employed the thymidine kinase (tdk) mutant strain as our wild-type genetic background.
We were able to obtain mutant strains for genes BT1522, BT1523, BT1524, and BT1526.
Deletion mutants for the BT1525 gene could not be obtained after many rounds of negative selection, suggesting that BT1525 is an essential gene in B. thetaiotaomicron. Lipid
analyses by LC-MS of TM and OMVs showed no IPC content in the BT1523 mutant and
negligible IPC levels (,1% relative abundance) for the BT1522 and BT1526 mutants
(Fig. 3, Fig. S2; Table S1) in both the TM and OMV fractions (Fig. 4). The BT1524 mutant
strain showed signiﬁcantly lower IPC relative abundance than the wild-type strain in
both fractions (Fig. 4). Conversely, the BT1524 mutant displayed higher relative abundance levels of PI in the TM than the wild-type strain (Fig. 4), suggesting that BT1524
impacts the synthesis of IPC through an unknown mechanism. PI was not detected in
the BT1523 and BT1526 mutants in either fraction, in agreement with their predicted
functions in PI biosynthesis. The BT1522 mutant strain displayed relative abundance levels of PI indistinguishable from those of the wild-type strain (Fig. 4). In agreement with
abolished IPC synthesis, membranes from the BT1522, BT1523, and BT1526 strains displayed higher levels of ceramides than wild-type and BT1524 mutant strains (Table S1).
The mutants in the IPC displayed mild growth defects (Fig. S3). Complementation of the
BT1522–1526 mutated genes restored the IPC lipid proﬁling in all the individual mutants
(Fig. 3, right panel), conﬁrming that the operon is necessary and sufﬁcient for IPC biosynthesis in B. thetaiotaomicron.
Depletion of IPC does not affect OMV biogenesis or cargo. IPC could be required
for OMV biogenesis, or alternatively it could mediate interactions with proteins,
impacting the OMV cargo. We analyzed B. thetaiotaomicron cells and OMV preparations using transmission electron microscopy (TEM) and found no obvious differences
in morphology between wild-type and IPC mutant strains (Fig. 5A; Fig. S4). We also
Volume 10 Issue 1 e00634-21
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FIG 2 Proposed genes and pathway for IPC synthesis. (A) Schematic representation of the BT1522–1526 hypothetical IPC biosynthesis operon with the
predicted gene function estimated by PSI-BLAST, HHpred, and Phyre2 analysis. (B) Schematic overview of the predicted IPC biosynthetic pathway. Pase,
phosphatase.

FIG 3 ESI MS spectra showing absolute counts of the [M–H]2 ions of IPC and PI molecules of TM lipids extracted from wild-type and BT1522–1526 mutants
(left panel) and their complemented strains (right panel). The orange arrows indicate IPC lipid species; the purple arrows indicate PI lipid species. The
graphs are representative of three biological replicates.

found similar levels of vesiculation, vesicles sizes, and OMV protein concentration
among all strains (Fig. S4 and Fig. 5B). Analysis of TM and OMV protein contents using
SDS-PAGE and Coomassie blue stain showed indistinguishable protein band patterns
between the wild-type and BT1522–1526 mutant strains (Fig. 6A). Western blot assays
of the TM and OMV fractions revealed that, despite their mild growth defects, the mutant strains do not lyse spontaneously, as evidenced by the lack of RNA polymerase
signal in OMV preparations (Fig. 6B).
As mentioned, Bacteroides preferentially packs OMVs with certain lipoproteins that
are mainly acidic and have hydrolytic activity, resulting in the selection of cargo components and the exclusion of other abundant OM proteins (21, 22, 44). To examine
whether BT1522–1526 mutant strains have an impact on protein cargo selection, we
analyzed SusG secretion into OMVs in the different strains. SusG is a lipoprotein with
amylase activity that has previously been shown to be preferentially packaged into
OMVs (22). Western blot assays of TM and OMV fractions of the different mutants
revealed no differences in SusG packaging into OMVs (Fig. S5). Together, these data
rule out a major role for IPC in OMV formation or cargo selection.
DISCUSSION
In this work, we determined the lipid composition of OMVs produced by B. thetaiotaomicron. LC-MS analysis demonstrated that sphingolipid species represent more than
Volume 10 Issue 1 e00634-21
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FIG 4 Relative abundances of IPC and PI species from TM and OMV fractions. The graphs show the
median values of two biological replicates with the range for individual lipid species from each
sample. Analysis of variance (ANOVA) tests were used to determine the statistical signiﬁcance with an
alpha value of 0.05; ****, P , 0.0001.

50% of the total lipid content of OMVs. Among these, EPC and IPC were the most abundant sphingolipids. We determined that the BT1522-1526 operon is essential for the synthesis of PI and IPC, the latter being the second most abundant sphingolipid species in
OMV fractions. BT1522–1526 mutant strains lacking IPC displayed mild growth defects,
but their OMV secretion phenotypes were indistinguishable from that of the wild-type
strain. Furthermore, protein cargo selection into OMVs was not affected in the different
mutants analyzed, indicating that IPC is not required for OMV biogenesis.
The results from this study indicate that the protein encoded by BT1522 is the main
IPC synthase in B. thetaiotaomicron. Remarkably, the detection of very low levels of IPC
in membranes from the BT1522 mutant strain suggests partial redundancy by an
unknown enzyme that could be acting as an IPC synthase in a suboptimal manner.
Moreover, higher levels of dihydroceramide and dehydrated ceramide (Table S1) in the
BT1522, BT1523, and BT1526 mutants in comparison to those in the wild-type and
BT1524 strains strongly suggest that these lipid molecules are the precursors for IPC
synthesis in B. thetaiotaomicron. Intriguingly, our results have also shown that in the
Volume 10 Issue 1 e00634-21
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FIG 5 (A) Transmission electron microscopy of B. thetaiotaomicron wild-type (WT) and DBT1522–1526 strains showing
no signiﬁcant differences in shape. The strains were grown on BHI agar plates, and bacterial lawns were swabbed
from the surface of the plates and resuspended in PBS for imaging by TEM. These images were acquired from Wandy
Beatty at the WUSTL Molecular Microbiology Imaging Facility. Magniﬁcation of 20,000 is shown. (B) TM and OMV
fractions were prepared using early stationary-phase liquid-grown cultures of WT and DBT1522–1526 strains. The TM
and OMV preparations were resuspended in PBS for each strain, and the total protein concentration was determined.
The graph shows the means and error bars by standard deviation (SD) of 3 biological replicates for each strain.
Statistical signiﬁcance was determined by t test (P value, ,0.05).

BT1524 mutant, the PI accumulation in TM was not reﬂected in the OMV fraction, as
was observed in the BT1522 mutant (Fig. 4, lower panels). Future work will help to elucidate the function of BT1524 in IPC synthesis and whether it is linked to the selection
of OMV lipid cargo in B. thetaiotaomicron.
Regarding the impact of PI/IPC on cell growth, our results suggest that while a lack of
IPC partially impacts the exponential growth phase, its absence could have a role in survival after reaching the stationary phase. P. gingivalis, B. fragilis, and B. thetaiotaomicron
lacking SPT activity display a reduction in growth and post-stationary-phase viability,
suggesting that IPC could be mediating this phenotype in B. thetaiotaomicron (37, 39).
Regarding other lipids with potential signaling activities within the host milieu, our
results showed very similar levels of GS between TM and OMVs. A recent study has
shown that the gene glsB (BT3459) from B. thetaiotaomicron is required for the synthesis
of GS, providing a partial genetic basis for amino lipid production in Bacteroidetes (55).
Volume 10 Issue 1 e00634-21
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FIG 6 TM and OMV fractions were prepared using early stationary-phase liquid-grown cultures. The
TM and OMV preparations were resuspended in PBS, and the protein concentration was determined:
10 m g protein per sample was loaded onto 12% SDS-PAGE gels and analyzed by (A) Coomassie blue
staining or (B) Western blot, using anti-RNA polymerase antisera and REVERT total protein stain as the
loading control. Lack of IPC does not cause cell lysis or impact the differential TM/OMV protein
proﬁle.

Similar to sphingolipids, GS are also required for bacterial homeostasis and colonization
of the murine gut (55). A speciﬁc serine-containing lipid from P. gingivalis, called lipid
654, can be cleaved by host phospholipases into lipid 430, a highly inﬂammatory derivative (52). Amino lipids signal inﬂammation through host TLR2 receptors and have been
proposed as markers of atherosclerosis (52, 53, 70, 71). Nevertheless, the potential contributions of amino lipids to OMV formation and gut inﬂammation by B. thetaiotaomicron
are still unknown. The majority of B. thetaiotaomicron cells reside within the colonic mucus layer in mice, and a small proportion localize within colonic crypts in close association to epithelial cells (72–76). Data from irritable bowel disease (IBD) patients show that
a decrease in Bacteroides sphingolipids is negatively correlated with an increase in host
ceramides, in comparison to a healthy human cohort (13, 35). Recent data from the Ley
group has showed that sphingolipids from Bacteroides are likely to be incorporated in
vivo into colonic epithelial cells and modify the host glucose metabolism (77). In vitro
studies in P. gingivalis also showed the incorporation of bacterial sphingolipids into THP I
human cell lines in a contact-independent manner and a decreased inﬂammatory
response from the host cell compared to that in SPT-deﬁcient strains (40, 78). Altogether,
these results indicate that sphingolipid-enriched OMVs act as carriers of secreted antiinﬂammatory signals within the colonic niche and are taken up by host colonocytes (79).
This mechanism of sphingolipid delivery could bypass the distance imposed by the colonic mucus barrier between Bacteroides cells and colonic epithelial cells. Our data, along
Volume 10 Issue 1 e00634-21
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with the work of others, show an opportunity to use targeted sphingolipid-deﬁcient bacterial strains to genetically dissect the contribution of the Bacteroides sp. cell envelope to
colonic homeostasis and gut symbiosis. B. fragilis, the Bacteroides species most frequently isolated from anaerobic infections in humans, lacks a BT1522–1526 orthologous
region in its genome. Gain-of-function experiments incorporating genes from the
BT1522–1526 region into a different Bacteroides species such as B. fragilis could contribute to dissecting the role of IPC synthesis genes in a heterologous context. While sphingolipids are the main lipid components of Bacteroides sp. membranes, we and others
have shown that lipid repertoires vary according to the species analyzed (35, 37, 38, 43,
77). We thus hypothesize that any contributions of Bacteroides sphingolipids to health or
disease states will likely be governed by the species composition and relative abundance
within each host microbiome.

Bacterial strains and growth conditions. Oligonucleotides, strains, and plasmids are described in
Table S2 in the supplemental material. Escherichia coli strains were grown in lysogenic broth (LB) or on LB
agar plates. Bacteroides strains were grown in an anaerobic chamber (Coy Laboratories) using an atmosphere
of 10% H2, 5% CO2, 85% N2. For liquid and solid growth, brain heart infusion (BHI) or BHI agar plates supplemented with hemin and vitamin K3 were used. Antibiotics and other compounds were used as follows:
ampicillin at 100 m g/mL, erythromycin at 25 m g/mL, and bromodeoxyuridine at 200 m g/mL. For growth
curves, overnight cultures of B. thetaiotaomicron wild-type and mutant strains were back-diluted into 96-well
plates using BHI equilibrated to an anaerobic atmosphere. A ﬁnal volume of 0.2 mL per well was used, and
the optical density at 600 nm (OD600) was adjusted to 0.1. Plates containing an anaerobic atmosphere were
sealed with non-gas permeable transparent ﬁlm and incubated at 37°C inside a temperature-controlled plate
reader (Synergy HTX, BioTek Instruments). OD600 measurements were taken every 15 min.
Construction of plasmids, mutagenesis, generation of mutants by clean deletion and complementation.
Generation of B. thetaiotaomicron deletion strains was carried out using the Dtdk strategy as previously
described (57). Brieﬂy, 1,000-bp upstream and downstream fragments of BT0870, BT1522, BT1523, BT1524,
BT1525, and BT1526 were cloned into the pExchange-tdk vector using E. coli S17-1 l pir as the cloning
strain. Constructs were conjugated into B. thetaiotaomicron Dtdk cells using previously transformed E. coli
S17-1 l pir as the donor, and strain plating and selection were performed as previously described (57).
For complementation of the mutant strains, BT1522, BT1523, BT1524, and BT1526 were PCR ampliﬁed
and puriﬁed. Each fragment was cloned into the pWW3867 integrative plasmid backbone using the
Gibson DNA assembly method (NEB) (72). E. coli S17-1 l pir was used as the cloning strain, and each construct was conjugated into the corresponding B. thetaiotaomicron DBT1522–1526 mutant strains
(Table S2). Positive transformants were selected by antibiotic resistance as described previously (57).
OMV preparations. Crude OMVs were obtained by ultracentrifugation of the ﬁltered spent medium
from 150 mL of liquid culture as described (21). Brieﬂy, 18- to 20-h cultures of B. thetaiotaomicron were
centrifuged at 6,500 rpm at 4°C for 10 min. To remove residual cells, the supernatant was ﬁltered using a
0.22-mm-pore membrane (Millipore). The ﬁltrate was subjected to ultracentrifugation at 200,000  g for
2 h (Optima L-100 XP ultracentrifuge; Beckman Coulter). The supernatant was discarded, and the pellets
containing the OMV preparation were resuspended in phosphate-buffered saline (PBS) and normalized
by OD before protein and lipid analyses. The OMV amount was estimated by measuring the protein content using a DC protein assay kit (Bio-Rad). Fractions were aliquoted and stored at 280°C until analyzed.
Membrane preparations. Total membrane preparations were obtained by cell lysis and ultracentrifugation as previously described (21). The total membranes from 150 mL of liquid culture were resuspended in PBS using a 2-mL glass tissue grinder with a polytetraﬂuoroethylene (PTFE) pestle (VWR). The
protein content was quantiﬁed using a DC protein assay kit (Bio-Rad). The fractions were aliquoted and
stored at 280°C until analysis.
Total lipid extractions. Total lipids from OMVs and TM were extracted based on the Bligh and Dyer
chloroform:methanol method (80). Brieﬂy, 2 volumes of methanol, 1 volume of chloroform, and 0.8 volumes of Milli-Q water were added to 1 volume of PBS-resuspended OMV or TM fractions in solvent-resistant glass tubes. The contents were mixed for 1 min by vortexing, and 1 volume of chloroform was
added to the mixture. The contents were mixed for another minute, and the tubes were centrifuged for
5 min at 4,000 rpm. After centrifugation, the bottom phase (organic) was recovered using a glass
Pasteur pipette and stored in solvent-sealed vials at 280°C until lipid analysis by LC-MS.
LC-MS analysis of lipids from TM and OMVs. Untargeted LC/MS analyses were conducted on an
Agilent 6550 A QTOF instrument with an Agilent 1290 high-performance liquid chromatograph (HPLC) with an
autosampler, operated using Agilent MassHunter software (Santa Clara, CA, USA). Separation of the total lipid
extracts was achieved using a Thermo Fisher (Waltham, MA, USA) BETASIL C18 column (100  2.1 mm, 5 m m)
at a ﬂow rate of 300 m L/min at room temperature. The mobile phase contained 5 mM ammonium formate
(pH 5.0) both in solvent A, acetonitrile:water (60:40, vol/vol), and solvent B, isopropanol:acetonitrile (90:10, vol/
vol). A gradient elution was applied in the following manner: 68% A, 0 to 1.5 min; 68 to 55% A, 1.5 to 4 min; 55
to 48% A, 4 to 5 min; 48 to 42% A, 5 to 8 min; 42 to 34% A, 8 to 11 min; 34 to 30% A, 11 to 14 min; 30 to 25%
A, 14 to 18 min; 25 to 3% A, 18 to 23 min; 3 to 0% A, 25 to 30 min; 0% A, 30 to 35 min; 68% A, 35 to 40 min.
Both the positive-ion and negative-ion electrospray ionization (ESI) MS scans were acquired in the mass range
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of 200 to 2,000 Da at a rate of 2 scans/min. High-resolution (R = 100,000 at m/z 400) mass spectrometric analyses of the lipid extracts were also conducted on a Thermo LTQ Orbitrap Velos. Lipids were loop injected into
the ESI ion source using a built-in syringe pump which was set to continuously deliver a ﬂow of 20 m L/min
methanol with 0.5% NH4OH. The scanned mass spectra were recalibrated internally with a known mass,
namely, 13:0/15:0 PE at m/z 634.4453. Linear ion trap (LIT) multistage MS (MSn) spectra were obtained for structural identiﬁcation as described previously (81–83).
Transmission electron microscopy. For negative staining and analysis by TEM, bacterial suspensions
in PBS or OMV were allowed to absorb onto freshly glow-discharged Formvar/carbon-coated copper grids
for 10 min. The grids were washed in distilled water and stained with 1% aqueous uranyl acetate (Ted
Pella, Inc., Redding, CA) for 1 min. Excess liquid was gently wicked off, and the grids were allowed to air
dry. The samples were viewed on a 1200EX transmission electron microscope (JEOL USA, Peabody, MA)
equipped with an 8-megapixel digital camera (Advanced Microscopy Techniques, Woburn, MA).
SDS-PAGE and Western blot analysis. The total membrane and OMV fractions were analyzed using
standard 12% Tris-glycine SDS-PAGE gels. Brieﬂy, 10 m g of TM or OMV fractions were loaded onto SDS-PAGE
gels in duplicate. One gel was stained with Coomassie blue to visualize the protein band patterns. The other
gel was transferred onto a 0.45-m m nitrocellulose membrane (Bio-Rad), and Western blotting was performed
using the LI-COR system. After transfer of the protein preparations from the SDS-PAGE gels, nitrocellulose
membranes were incubated with REVERT total protein stain as described by the manufacturer (LI-COR) and
imaged immediately at 680 nm. The membranes were blocked using Tris-buffered saline (TBS)-based 3%
nonfat milk blocking solution. The primary antibodies used in this study were mouse monoclonal anti-E. coli
RNA polymerase (RNApol) subunit alpha (BioLegend). The secondary antibodies used were IRDye antimouse
780 antibodies (LI-COR). Imaging was performed using an Odyssey CLx scanner (LI-COR).
Data availability. The resulting lipidomic data are available at the NIH Common Fund’s National
Metabolomics Data Repository (NMDR) website, https://www.metabolomicsworkbench.org (84), where
they have been assigned project ID PR001199. The data can be accessed directly via https://doi.org/10
.21228/M8QQ5J.
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